3 to 5 years sounds like his opinion rather than an industry accepted date. Based on acceptance and public demand, I think it likely to come sooner than that and whilst access will vary state to state, one could reasonably expect that the regulatory framework for MC prescriptions will be in place within the next year or so (IMO). Auscann is certainly doing a lot to help doctors in being more comfortable with this revolutionary new medical treatment becoming available to them in the lead up to production.
AC8
Price at posting:
$1.43 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.